Skip to main content
. 2022 Jul 25;61(3):107. doi: 10.3892/ijo.2022.5397

Figure 3.

Figure 3

Bioluminescence imaging of U87 and U373 cells after applying tumor-treating fields for 72 h. Data are presented as the average ± SD (n=5). *P<0.001 and **P<0.05. For the U87TTF and U373TTF experiments, 'TTF' indicates 'treated with tumor-treating fields'.